Blog

PCR Genotyping: A Precision Tool for Modern Genetic Analysis

PCR Genotyping: A Precision Tool for Modern Genetic Analysis

Introduction: Understanding PCR Genotyping

PCR genotyping – also known as genotyping by PCR – is a powerful molecular technique used to identify genetic variation within DNA sequences. Leveraging the high specificity of polymerase chain reaction (PCR), researchers and breeders can accurately detect single nucleotide polymorphisms (SNPs) and insertions or deletions (Indels) with high accuracy. PCR genotyping offers a cost-effective, high-throughput, and scalable solution for SNP validation, marker-assisted selection (MAS), and genomic selection (GS) in both plant and animal breeding programs.

Infographic illustrating where PCR genotyping with PACE® sits in a typical genomics workflow

What is PCR Genotyping?

PCR genotyping involves amplifying specific DNA sequences using allele-specific primers to distinguish between genetic variants. Techniques like allele-specific PCR – including 3CR Bioscience’s proprietary PACE® chemistry– are widely adopted due to their accuracy, sensitivity, and adaptability to high-throughput formats. Unlike sequencing methods that require complex data processing, PCR genotyping delivers rapid, actionable insights into genetic traits with minimal sample preparation and runtime.

As von Maydell (2023) notes in  “PCR allele competitive extension (PACE).” Plant Genotyping: Methods and Protocols. New York, NY: Springer US, SNPs—codominant, genome-wide, and highly abundant—are crucial for modern molecular-genetic research, enabling applications such as GWAS, QTL mapping, and MAS. PACE, in particular, excels when analyzing a small number of SNPs across large sample sets, such as in sex determination, genetic mapping, and validation of crosses.

An infographic showing the positioning of PACE with other genotyping technlogies.

PCR Genotyping vs. Sequencing Methods

While next-generation sequencing (NGS) and genotyping-by-sequencing (GBS) are ideal for SNP discovery, PCR genotyping offers distinct advantages for routine marker validation and screening:

  • Cost: PCR genotyping is significantly more affordable for moderate-scale projects (1-100 markers).
  • Speed: Faster turnaround due to simplified analysis and minimal data processing.
  • Data Volume: Sequencing generates large, often redundant datasets; PCR genotyping focuses on known, relevant SNPs.
  • Scalability: PCR genotyping platforms like 3CR’s GeneArrayer efficiently processes hundreds to thousands of samples.

Applications of PCR Genotyping in Breeding Programs

In agriculture and livestock genetics, PCR-based SNP genotyping—especially using PACE—plays a pivotal role in:

  • Marker Validation: Essential following SNP discovery via GBS or GWAS, confirming that markers are linked to traits of interest.
  • Marker-Assisted Selection (MAS): Rapid screening for desirable traits, such as disease resistance, yield, or fertility.
  • Genomic Selection (GS): Feeding validated SNPs into prediction models to estimate breeding values and drive genetic gain.

Advantages of PCR Genotyping with Allele-Specific PCR

  • Precision and Specificity: Allele-specific PCR ensures accurate discrimination between alleles, critical for trait association.
  • Flexibility: Custom primer design enables researchers to target specific loci relevant to breeding objectives.
  • High Throughput: PCR genotyping can process large sample sizes efficiently without compromising on data quality.
  • Cost-Effectiveness: Ideal for focused studies where sequencing is excessive or impractical.

Flexibility and Customization

Allele-specific PCR offers exceptional flexibility. Researchers can design primers targeting SNP loci associated with key breeding objectives, streamlining selection and improving outcomes. Its scalability supports diverse breeding projects—from targeted trials to population-wide screens.

As highlighted by von Maydell, primer design is a foundational step. A list of SNP-containing sequences can be submitted for rapid assay development. No reference genome is required, making PACE accessible for non-model organisms with limited genetic data.

Validation of Marker-Trait Associations

Accurate validation of SNP-trait links ensures the reliability of MAS strategies. Allele-specific PCR allows researchers to test associations across varied genotypes and environments. Including homozygous, heterozygous, and control samples, strengthens confidence in marker efficacy.

Integration with Genomic Selection

Validated SNP markers are key inputs in genomic prediction models. PCR genotyping provides the genotypic data needed to estimate breeding values, allowing earlier and more accurate selection. This synergy accelerates genetic improvement and enhances breeding efficiency.

SNP genotyping with allele-specific PCR is the preferred method for validating genetic markers in breeding programs, offering unmatched sensitivity, specificity, and customization options. By leveraging PCR genotyping, researchers and breeders can efficiently validate marker-trait associations, enhance genomic selection strategies, and expedite progress toward breeding objectives. In a field where efficiency and precision are crucial, adopting SNP genotyping with allele-specific PCR is a strategic investment in the future of agricultural and livestock breeding and genetic improvement.

Why Choose PACE® for PCR Genotyping?

PACE (PCR Allele Competitive Extension) from 3CR Bioscience represents a leap forward in PCR genotyping chemistry.

PACE 2.0 offers enhanced signal clarity and tighter clustering especially with tricky or crude DNA samples, while PACE OneStep RT PCR enables simultaneous reverse transcription and genotyping in a single tube.

A schematic showing the components of a PACE PCR genotyping reaction.

3CR Bioscience’s Genotyping Solutions:

Automating PCR Genotyping: 3CR’s GeneArrayer Platform

Automation significantly enhances PCR genotyping:

  • Throughput & Speed: Thousands of samples processed daily with minimal hands-on time.
  • Consistency: Standardized pipetting and thermal cycling enhance reproducibility.
  • Scalability: Easily adaptable from small-scale validation to extensive population studies.
  • Cost Efficiency: Reduced labour, waste, and reruns lower the per-sample cost.

3CR’s integrated platforms —GeneExtract, GeneArrayer, GeneCycler, and GeneScanner—enable seamless DNA processing from extraction to data analysis.

Case Studies: PACE in Action

Real-world applications of PACE PCR genotyping underscores its impact:

Conclusion: The Future of Genetic Analysis Lies in PCR Genotyping

PCR genotyping, particularly with PACE genotyping chemistry, bridges the gap between SNP discovery and trait selection, offering speed, affordability, and precision for life science researchers, biotech pioneers, agricultural researchers, and breeders alike. As von Maydell (2023) emphasizes, allele-specific systems like

PACE are ideal for reanalyzing validated SNPs across multiple genotypes—providing unmatched efficiency for genetic improvement.

MORE POSTS

PCR Genotyping: A Precision Tool for Modern Genetic Analysis
PCR genotyping is a fast, cost-effective method for validating genetic markers. Using technologies like PACE®, it enables precise, high-throughput SNP analysis for breeding and genetic research programs.
DNA Extraction Instruments
3CR Bioscience's GeneExtract H9600 and H384 offer fast, cost-effective, high-throughput automated DNA extraction, delivering superior purity and efficiency for genotyping, sequencing, and biotech applications.
CRIPSR workflows
Transforming CRISPR Gene Editing Workflows: High-Throughput Edit Screening with PACE Genotyping
[fibosearch]
Name(Required)
This field is for validation purposes and should be left unchanged.

Contact us

MEET OUR TEAM

Steve Asquith Managing Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John Holme Technical Director
John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base. During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASPâ„¢, KlearKall, KlearGene, KlearAmp and KlearTaqâ„¢, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.
Dr. Nisha JainOperations Director
Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP. Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.
Nazma Saffin General Manager
For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.
Jon Curtis Non-Executive Chair
After 8 years in The Royal Air Force, Jon moved to the Imperial Cancer Research Fund where he pioneered the use of ultra high-throughput genomic automation, capable of 46,000 PCRs per hour. In the 1990’s Jon joined GlaxoSmithKline, implementing a high-throughput genomics platform into their drug discovery pipeline. Whilst there he also developed acoustic mixing into compound management, becoming the gold standard across pharma. Jon developed the world’s first commercially viable 1536-well PCR plates, automated thermal & laser plate-sealer, plus automated liquid-handling & tip washing tools to reduce waste and costs. In 2002 Jon co-founded KBioscience with Phil Robinson, utilising ultra high-throughput PCR instrumentation & a suite of automation tools to create the company’s SNPline robotic platform, with a capacity of 250,000 PCRs/day. The business was underpinned by their ground-breaking patented genotyping chemistry, KASP™, which has over 10,000 scientific papers to date. In November 2022 Jon joined 3CR Bioscience acting as an advisor bringing his commercial and scientific experience to the company.